Economic Evaluations

Invited presentation

Objectives: In trial-based economic evaluation, some individuals are typically associated with missing data at some time point, so that their corresponding aggregated outcomes (eg, quality-adjusted life-years) cannot be evaluated. Restricting the …

Contributed presentation

Patient-level health economic data collected alongside clinical trials are an important component of the process of technology appraisal, with a view to informing resource allocation decisions. For end of life treatments, such as cancer treatments, …

Three day short course"

Health economic evaluations based on patient-level data collected alongside clinical trials (e.g. health related quality of life and resource use measures) are an important component of the process which informs resource allocation decisions. Almost …

Results from randomised trials show adding abiraterone acetate plus prednisolone (AAP) to standard of care (SOC) improves disease-free and overall survival in men with prostate cancer (PC) starting long-term hormone therapy for first time. Formal …

One day short course

Invited presentation

Contibuted poster